v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities:    
Net loss $ (95,537) $ (894,040)
Loss from discontinued operations, net of tax   806,408
Adjustments to reconcile net loss to cash (used for) provided by operating activities:    
Depreciation and amortization 127,442 85,888
Share-based compensation expense 7,094 9,293
Deferred income tax (benefit) provision (45,489) 8,789
Changes in operating lease right-of-use assets and lease liabilities 135 744
Gain from sale and dispositions of patient service equipment (58,779) (9,322)
Changes in operating assets and liabilities:    
Accounts receivable, net (24,175) 21,891
Inventories 1,090 (1,646)
Accounts payable 6,772 (4,739)
Net change in other assets and liabilities (1,403) (56,441)
Other, net 6,767 5,058
Cash provided by operating activities from discontinued operations 0 30,661
Cash (used for) provided by operating activities (76,083) 2,544
Investing activities:    
Additions to patient service equipment ($85,139 and $101,744) and other fixed assets (89,232) (103,416)
Proceeds from sale of patient service equipment 111,718 35,004
Additions to computer software (1,906) (3,877)
Other, net 2,100 (1,910)
Cash used for investing activities from discontinued operations 0 (26,918)
Cash provided by (used for) investing activities 22,680 (101,117)
Financing activities:    
Borrowings under Revolving Credit Agreement 548,600 1,630,184
Repayments under Revolving Credit Agreement (752,100) (1,495,184)
Proceeds from debt issuance 1,237,315  
Repayments of debt (1,237,315)  
Financing costs paid (16,791)  
Repurchase of common stock   (6,656)
Other, net (603) (178)
Cash used for financing activities from discontinued operations   (3,689)
Cash (used for) provided by financing activities (220,894) 124,477
Effect of exchange rate changes on cash and cash equivalents (41) 1,801
Net (decrease) increase in cash and cash equivalents (274,338) 27,705
Cash and cash equivalents at beginning of period 281,989 49,382
Cash and cash equivalents at end of period 7,651 77,087
Supplemental disclosure of cash flow information:    
Income taxes paid, net 19,604 5,458
Interest paid 79,324 65,845
Noncash investing activity:    
Unpaid purchases of patient service equipment and other fixed assets at end of period $ 52,684 $ 73,437